Bicara Share Price

Bicara Share Price

NASDAQ: BCAX | Mega Cap | Healthcare
$8.46
-$0.65 (-7.19%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Bicara Stock Performance

Open
$9.00
Prev. Close
$9.12
Circuit Range
N/A
Day Range
$8.44 - $9.10
Year Range
$7.87 - $30.93
Volume
35,366
Average Traded
$8.75

Bicara Share Price Today

As of 22 November 2026, Bicara Therapeutics Inc.'s share price is $8.46. The stock opened at $9.00, compared to its previous close of $9.12. During today's trading session, Bicara Therapeutics Inc.'s share price traded between $8.44 and $9.10, with an average price of $8.77. Over the past 52 weeks, the stock has recorded a high of $30.93 and a low of $7.87. In terms of performance, Bicara Therapeutics Inc.'s share price has declined by 61.09% over the last six months and is down 54.37% on a year-on-year basis.

Bicara Share Price Chart

Line chart of the Bicara price trend over the selected period. The price fell overall, ranging from 8.44 to 9.14, ending at 8.46.
$8.44$9.10
L
Show Current Price
H

Bicara Stock Fundamentals & Key Indicators

Market Cap
$462.57B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.32
Revenue (TTM)
$0.00
Return On Equity (TTM)
-53.80%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-90.56%

Bicara Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$37.39-$56.21-$55.44-$71.25
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-50.33%1.37%-28.52%

Bicara Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$68.00-$137.95
Net Profit MarginN/AN/A
Income ChangeN/A-102.87%

Bicara Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets8.947.46
Current Assets422.05502.53
Total Assets430.99510.0
Non Current Liabilities0.590.13
Current Liabilities28.9517.99
Total Liabilities29.5418.12
Shareholders' Equity401.45491.88

Bicara Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-106.83-74.75
Investing-318.45-0.01
Financing32.26334.03

About Bicara

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.

Bicara Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.93
$8.46
-6.47%
Oct 2026
$19.05
$9.04
-51.48%
Sep 2026
$22.73
$18.64
-24.90%
Aug 2026
$26.24
$24.82
-8.41%
Jul 2026
$29.55
$27.10
-8.69%
Jun 2026
$21.02
$29.68
+36.52%
May 2026
$21.57
$21.74
+0.51%
Apr 2026
$20.14
$21.63
+8.83%
Mar 2026
$16.43
$19.88
+18.30%
Feb 2026
$17.00
$16.80
+0.00%
Jan 2026
$16.50
$16.80
-0.12%
Dec 2025
$17.82
$16.82
-9.28%

Bicara Share Price FAQs